@article{e0b3579c016941e0a9dcddcc2b0f03ea,
title = "Outcomes of 3 patients with adenosine deaminase deficiency on long-term enzyme replacement therapy",
author = "Gans, {Melissa D.} and Larry Bernstein and Jenny Shliozberg and Tatyana Gavrilova and Arye Rubinstein",
note = "Funding Information: Funding: Before the Food and Drug Administration approval, the patients were on bovine pegylated adenosine deaminase and recombinant pegylated adenosine deaminase in the clinical trials funded by Leadiant Biosciences, Inc., Pomezia, Italy.",
year = "2021",
month = may,
doi = "10.1016/j.anai.2020.12.008",
language = "English (US)",
volume = "126",
pages = "593--595",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "5",
}